• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Tak-721





















Hi I am one of the inventors of Tak 721 and very frustrated that the company will say nothing to us as to this ridiculous delay of an orphan drug with priority status. Any one know if Takeda received a CRL or what the hell the hold up is?